Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 5/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | ACP1 | P24666 | 1/20 | 0.38 |
| ▸ | PDE4A | P27815 | 1/20 | 0.38 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.38 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.38 |
| ▸ | PNPO | Q9NVS9 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.36 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.34 |
| ▸ | PGK1 | P00558 | 1/20 | 0.33 |
| ▸ | PGK2 | P07205 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | INPPL1 | O15357 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL459237 | 0.84 | TSHR (0.40) | FDPSTSHR | |
| SCHEMBL8905757 | 0.75 | GAA (0.39) | FDPSP2RX7GAACYP2C9CYP2C19 | |
| Pyrophosphoric Acid SCHEMBL459236 | 0.72 | FDPS (0.42) | FDPSP2RX7GAAINPPL1CYP2C9 | |
| SCHEMBL3365052 | 0.71 | HDAC6 (0.50) | TSHR | |
| SCHEMBL3359808 | 0.71 | ALDH1A1 (0.50) | CYP2C19 | |
| SCHEMBL28941065 | 0.71 | ESR1 (0.35) | ESR1PTGS1ACP1PDE4AP2RX1 | |
| SCHEMBL28941066 | 0.71 | ESR1 (0.38) | ESR1PTGS1ACP1PDE4AP2RX1 | |
| SCHEMBL8910883 | 0.71 | GAA (0.36) | FDPSGAACYP2C9CYP2C19 | |
| SCHEMBL31429819 | 0.71 | FDPS (0.37) | FDPSP2RX7PGK1PGK2GAA | |
| Phosphoric Acid SCHEMBL459067 | 0.70 | FDPS (0.38) | FDPSP2RX7PGK1PGK2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260022411-A1 | MICROBIAL CELL FACTORIES PRODUCING THIAMINE | BIOSYNTIA APS (DK) | 2026-01-22 | — | — | US | claimed |
| EP-4555076-A1 | MICROBIAL CELL FACTORIES PRODUCING THIAMINE | Biosyntia ApS (DK) | 2025-05-21 | — | — | EP | claimed |
| CN-119731312-A | Microbial cell factory for producing thiamine | 拜奥信尼亚私营有限责任公司 | 2025-03-28 | — | — | CN | claimed |
| US-20240368659-A1 | MICROBIAL CELL FACTORIES PRODUCING VITAMIN B COMPOUNDS | BIOSYNTIA APS (DK) | 2024-11-07 | — | — | US | claimed |
| EP-4370653-A2 | MICROBIAL CELL FACTORIES PRODUCING VITAMIN B COMPOUNDS | Biosyntia ApS (DK) | 2024-05-22 | — | — | EP | claimed |
| CN-117897476-A | Microbial cell factory for producing vitamin B compounds | 拜奥信尼亚私营有限责任公司 | 2024-04-16 | — | — | CN | claimed |
| WO-2024013212-A1 | MICROBIAL CELL FACTORIES PRODUCING THIAMINE | BIOSYNTIA APS (DK) | 2024-01-18 | — | — | WO | claimed |
| WO-2023285585-A2 | MICROBIAL CELL FACTORIES PRODUCING VITAMIN B COMPOUNDS | BIOSYNTIA APS (DK) | 2023-01-19 | — | — | WO | claimed |
| WO-2026099311-A2 | MICROBIAL CELL FACTORIES PRODUCING PROSTAGLANDINS | RIVER STONE BIOTECH APS (DK) | 2026-05-15 | — | — | WO | disclosed |
| US-20260022411-A1 | MICROBIAL CELL FACTORIES PRODUCING THIAMINE | BIOSYNTIA APS (DK) | 2026-01-22 | — | — | US | disclosed |
| EP-4555076-A1 | MICROBIAL CELL FACTORIES PRODUCING THIAMINE | Biosyntia ApS (DK) | 2025-05-21 | — | — | EP | disclosed |
| CN-119731312-A | Microbial cell factory for producing thiamine | 拜奥信尼亚私营有限责任公司 | 2025-03-28 | — | — | CN | disclosed |
| US-20250011804-A1 | INTERACTORS AND TARGETS FOR IMPROVING PLANT AGRONOMIC CHARACTERISTICS | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2025-01-09 | — | — | US | disclosed |
| US-20240368659-A1 | MICROBIAL CELL FACTORIES PRODUCING VITAMIN B COMPOUNDS | BIOSYNTIA APS (DK) | 2024-11-07 | — | — | US | disclosed |
| US-20110152215-A1 | RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH RIBOSWITCHES | YALE UNIVERSITY | 2011-06-23 | — | — | US | disclosed |
| US-20110150854-A1 | RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH RIBOSWITCHES | YALE UNIVERSITY | 2011-06-23 | — | — | US | disclosed |
| US-20100280803-A1 | Compositions and Methods for Modeling Saccharomyces cerevisiae Metabolism | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2010-11-04 | — | — | US | disclosed |
| US-7794931-B2 | Riboswitches, methods for their use, and compositions for use with riboswitches | YALE UNIVERSITY (US) | 2010-09-14 | — | — | US | disclosed |
| US-7751981-B2 | Articles of manufacture and methods for modeling Saccharomyces cerevisiae metabolism | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2010-07-06 | — | — | US | disclosed |
| US-20050053951-A1 | Riboswitches, methods for their use, and compositions for use with riboswitches | YALE UNIVERSITY | 2005-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050053951-A1 | Riboswitches, methods for their use, and compositions for use with riboswitches | NSUN3, RNGTT, SRRT | FDPS 203/4885ESR1 1036/4885PTGS1 2730/4885 |
| US-20110150854-A1 | RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH RIBOSWITCHES | NSUN3, RNGTT, SRRT | FDPS 199/4885ESR1 1006/4885PTGS1 2635/4885 |
| US-20260022411-A1 | MICROBIAL CELL FACTORIES PRODUCING THIAMINE | AHCY, SHMT1, MTHFD1 | FDPS 5/4885ESR1 4862/4885PTGS1 287/4885 |
| US-20110152215-A1 | RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH RIBOSWITCHES | NSUN3, RNGTT, SRRT | FDPS 199/4885ESR1 1006/4885PTGS1 2635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.